## Abstract Matrix metalloproteinases (MMPs) are zinc‐dependent proteases capable of degrading extracellular matrix components. The activity of these proteases is tightly regulated through the actions of the tissue inhibitors of metalloproteinases (TIMPs). Although the regulation of MMPs and TIMPs
BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells
✍ Scribed by Antonio R.G. Susperregui; Francesc Viñals; Patricia W.M. Ho; Matthew T. Gillespie; T. John Martin; Francesc Ventura
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 292 KB
- Volume
- 216
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Bone morphogenetic protein‐2 (BMP‐2) is strongly involved in the induction of osteoblast differentiation from mesenchymal cell precursors, as well as in enhancing bone matrix production by osteoblastic cells. Likewise, the osteoporotic phenotype of PTHrP deficient mice makes clear the importance of this paracrine regulator in bone physiology. Here, we report that BMP‐2 rapidly down‐regulated PTHrP gene expression through a transcriptional mechanism in pluripotent mesenchymal C2C12 cells, whereas BMP‐2 increased expression of PTHrP receptor. PTHrP did not significantly alter the BMP‐dependent Smad transcriptional pathway. Similarly, PTHrP did not significantly modify the BMP‐regulated expression of RANKL or OPG, cytokines involved in osteoclastogenesis. More importantly, addition of PTHrP, through the PKA signaling pathway, partially prevented the BMP‐dependent induction of some osteogenic markers such as Runx2 and Osterix in C2C12 cells. Our data suggest that BMP‐2 down‐regulation of PTHrP could facilitate terminal differentiation of osteoblasts. J. Cell. Physiol. 216: 144–152, 2008. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract The effects of Osteogenic Protein‐1 (OP‐1, BMP‐7) on the differentiation of the pluripotent mesenchymal cell line, C2C12, were examined. OP‐1 at 50 ng/ml partially inhibited myotube formation in C2C12 cells, while OP‐1 at 200 ng/ml completely inhibited myotube formation and induced the
## Abstract Suppressor of cytokine signaling (SOCS)‐2 regulates normal postnatal growth and its deficiency in mice causes gigantism with increased bone length and proportional enlargement in skeletal muscles. Using C2C12 mesenchymal precursor cell line as a model, we investigated a possible role of
## Abstract It is known that the MyoD family members (MyoD, Myf5, myogenin, and MRF4) play a pivotal role in the complex mechanism of skeletal muscle cell differentiation. However, fragmentary information on transcription factor‐specific regulation is available and data on their post‐transcriptiona
## Abstract Previous studies have shown that osteogenic protein‐1 (OP‐1; also known as BMP‐7) induces differentiation of the pluripotent mesenchymal cell line C2C12 into osteoblastic cells. OP‐1 also alters the steady‐state levels of messenger RNA (mRNA) encoding for the cartilage‐derived morphogen
## Abstract The transforming growth factor (TGF)‐β inducible early gene (TIEG)‐1 is implicated in the control of cell proliferation, differentiation, and apoptosis in some cell types. Since TIEG1 functioning may be associated with TGF‐β, a suppressor of myogenesis, TIEG1 is also likely to be involv